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Background:  Long menstrual cycle is a risk factor for developing type 2 diabetes and cardiovascular disease in women. We aimed 
to evaluate the association between existing type 2 diabetes and oligomenorrhea before diagnosis of diabetes, and to observe the 
differences in this association among obese and non-obese Korean women. 
Methods:  Patients with type 2 diabetes (n=118) and without any clinical evidence of abnormal glucose regulation (n=258) who 
attended the outpatient clinic of a university hospital and were over age 30. Patients self-reporting a menstrual cycle over 40 days 
during their 20s were defined as oligomenorrhea before diagnosis of diabetes. Obesity was defined as having a body mass index 
(BMI) over 25 kg/m
2. 
Results:  The frequency of oligomenorrhea before diagnosis of diabetes was almost two-fold higher in women with type 2 diabe-
tes than in the control group (16.1% vs. 8.5%, P=0.03). Oligomenorrhea was associated with type 2 diabetes after adjusting for 
age, BMI, systolic blood pressure, triglycerides, and high density lipoprotein cholesterol (odds ratio, 3.89; 95% confidence inter-
val, 1.37 to 11.04). Among women with oligomenorrhea before diagnosis of diabetes, the frequency of type 2 diabetes was signif-
icantly higher in obese subjects than in their non-obese counterparts (90.9% vs. 30.0%, P=0.03).
Conclusion:  Having a long menstrual cycle could be a risk factor for the development of type 2 diabetes, especially in obese 
women. 
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INTRODUCTION
Irregular menstrual cycles are frequently associated with sys-
temic diseases in women, and women with diabetes frequently 
have irregular menstrual cycles [1]. Several studies have shown 
that length of menstrual cycle is one of the risk factors for the 
development of type 2 diabetes [2-7]. Griffin et al. [4] reported 
that nearly 25% to 50% of young diabetic women of reproduc-
tive age suffer some form of menstrual dysfunction. A recent 
6-year follow up in the Nurses’ Health Study II (NHS II) re-
ported an increased risk of developing type 2 diabetes in wom-
en with long (40 days or more) or irregular menstrual cycle 
between the ages of 18 to 22 years [5,6]. A cross-sectional 
study of women in Pima India also showed an increased fre-
quency of type 2 diabetes in those women with a history of 
very long menstrual cycles [7]. 
  Polycystic ovary syndrome (PCOS) is the most common 
cause of oligo- or amenorrhea in premenopausal women and 
most women with PCOS are insulin resistant [8]. It is an im-
portant risk factor for type 2 diabetes and the prevalence of 
women with impaired glucose tolerance is strikingly higher in 
this population than in their age comparable counterparts [9]. 
PCOS could reflect the potential association between risk for 
type 2 diabetes and menstrual irregularities.
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  In this study, we tried to evaluate the association between 
currently having type 2 diabetes and oligomenorrhea before 
diabetes was diagnosed. We also attempted to evaluate the dif-
ferences in the association between oligomenorrhea and pres-
ence of type 2 diabetes among obese and non-obese Korean 
women.
METHODS
Study subjects
We enrolled 376 non-pregnant premenopausal women who 
attended the Department of Endocrinology outpatient clinic 
or the health center at Ewha Womans University Mokdong 
Hospital from April 2005 to February 2006. Among the 376 
women enrolled, 118 had type 2 diabetes and 258 acted as the 
control group. The women had presented for either an evalua-
tion of a thyroid nodule or a routine health examination with 
no clinical evidence of glucose intolerance or personal history 
of type 2 diabetes. We excluded any subject with type 1 diabe-
tes, previous gestational diabetes and/or family history of dia-
betes. The Institutional Review Board of Ewha Womans Uni-
versity Mokdong Hospital approved the study. Informed con-
sent was obtained from all participants. We certify that all ap-
plicable institutional and governmental regulations concern-
ing the ethical use of human volunteers were followed during 
this research. 
  Participants completed a questionnaire about menstrual 
history including the number of days between menstrual cy-
cles during adolescence, ages 20 to 29 and at present, current 
menstrual duration, age at menarche, history of severe teenage 
acne, hirsutism and lifestyle factors, such as regular exercise, 
smoking and alcohol consumption. Use of medications known 
to affect the menstrual cycle, including oral contraceptives, 
was also evaluated (Fig. 1). Anthropometric measurements 
were obtained, including body mass index (BMI) and waist 
circumference. Systolic and diastolic blood pressures were 
measured. Fasting serum glucose levels were measured using 
the glucose oxidase method and lipid profiles, including total 
cholesterol, high density lipoprotein cholesterol (HDL-C), and 
triglycerides (TG) were measured using enzymatic methods.
We categorized women as oligomenorrhea before the diagno-
sis of diabetes, if their menstrual cycle length during their 20s 
was over 40 days. We only enrolled subjects over 30 years old, 
since oligomenorrhea during a woman’s 20s could be a pheno-
typic finding of diabetes. 
  We divided the subjects into obese (BMI ≥25 kg/m
2) and 
non-obese (BMI <25 kg/m
2) according to their present body 
weight.
Statistical analysis
Data were analyzed using SAS version 9.1 statistical software 
(SAS Institute, Cary, NC, USA). Because TG and HDL-C re-
sults showed slightly skewed distribution, analyses were per-
formed using log-transformed data. Although mean values are 
shown for untransformed data, all P values are based on log-
transformed data. Unadjusted associations between type 2 di-
abetes and potential risk factors were evaluated using the Stu-
dent’s t-test and χ
2 test. Stratified analysis using the Cochran-
Mantel-Haenszel test was performed to control for obesity as a 
confounding factor to the relationship between type 2 diabetes 
as an outcome variable and risk factors. Additionally, the Bres-
low-Day test for homogeneity was performed. Multiple logis-
tic regression analyses were used to assess the independent 
contribution of oligomenorrhea during the participants’ 20s to 
type 2 diabetes. Age, BMI, systolic blood pressure, TG, HDL-
C, smoking, alcohol and exercise were used as covariates. All P 
values are two-tailed and statistical significance was defined as 
a P value less than 0.05.
RESULTS
Women with type 2 diabetes were significantly older and more 
obese than the control subjects. The mean age was 45±5 years 
I. Menstrual cycle
1) Regularity
2) Cycle
3) Duration
4) Last menstrual period
5) Previous menstrual periods
II. Past history
1) Regularity
2) Age of menarche
3) Menstrual cycle
a) Menarche-19 yr
b) 20-29 yr
4)   Presence of irregular menstrual cycle length
5) Medical or hormonal therapy
6) Acne at adolescent
7) Hirsutism at adolescent
Fig. 1.  Questionnaire about menstrual and past medical his-
tory and lifestyle. 
III. Pregnancy history
IV. Life style habits
1) Physical activity/exercise
2) Smoking history
3) Alcohol history
V.   Any past medical or medication 
history386
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in women with type 2 diabetes and 40±5 years in the control 
subjects (P<0.001). Mean BMI and waist circumference were 
25.1±4.3 kg/m
2 and 84.2±9.9 cm in women with type 2 dia-
betes and 22.2±2.7 kg/m
2 and 74.4±6.6 cm for the control 
group (P<0.001). Systolic blood pressure, fasting serum glu-
cose, total cholesterol, and TG were also significantly higher 
and HDL-C was significantly lower in women with type 2 dia-
betes than in the control subjects (Table 1).
  The menstrual history of women with type 2 diabetes and 
the control subjects is shown in Table 2. The current menstrual 
cycle was significantly longer in women with type 2 diabetes 
than in the control group (32.2±8.4 vs. 30.2±6.4 days, P=
0.02). The frequency of oligomenorrhea from age 20 to 29 was 
almost two-fold higher in women with type 2 diabetes than in 
the control subjects (16.1% vs. 8.5%, P=0.03). The menstrual 
cycles during participants’ adolescence and 20s was slightly 
longer in women with type 2 diabetes than in the control group; 
however, the difference was not statistically significantly. 
  Menstrual duration were significantly longer in participants 
with type 2 diabetes (5.2 vs. 4.9 days, P<0.01), but age at men-
arche did not differ significantly between the two groups. The 
frequency of oligomenorrhea before the diagnosis of diabetes 
or from age 20 to 29 was 18.9% for obese women with type 2 
diabetes, 13.9% for non-obese women with type 2 diabetes and 
8.5% for the control subjects (P for trend=0.01, Fig. 2). In mul-
tiple logistic regression analysis, oligomenorrhea was signifi-
cantly associated with type 2 diabetes after adjusting for age, 
BMI, systolic blood pressure, TG, and HDL-C (odds ratio [OR], 
3.89; 95% confidence interval [CI], 1.37 to 11.04; Table 3). The 
OR remained significant after the addition of lifestyle factors, 
such as regular exercise, smoking and alcohol consumption, as 
covariates (OR, 4.84; 95% CI, 1.64 to 14.28). We also compared 
the frequency of type 2 diabetes according to obesity and oli-
gomenorrhea from age 20 to 29 (Table 4). Forty-one subjects 
had a past history of oligomenorrhea in their 20s. Among them, 
11 were obese and 30 were non-obese. The frequency of type 2 
diabetes was 90.9% (10 of 11) in obese women with a history 
of oligomenorrhea and 30.0% (9 of 30) in their non-obese 
counterparts. In contrast, 43 of 83 (51.8%) obese women with-
out a history of oligomenorrhea and 56 of 252 (22.2%) non-
obese women were diabetic patients. Additionally, when we 
performed the Cochran-Mantel-Haenszel stratified analysis to 
consider the possibility of an interaction between obesity, oli-
Table 1.  Clinical characteristics of subjects
Characteristic
Diabetics 
(n=118)
Control 
(n=258) P value
Age (range), yr  45±5 (31-54) 40±5 (31-53) <0.001
BMI, kg/m
2 25.1±4.3 22.2±2.7 <0.001
Waist, cm 84.2±9.9 74.4±6.6 <0.001
SBP, mm Hg 128±16 119±14 <0.001
DBP, mm Hg 76±11 71±10 <0.001
Fasting glucose, mg/dL 169.9±54.1 89.4±7.4 <0.001
Total cholesterol, mg/dL 190.4±49.7 176.8±30.2 <0.001
Triglycerides, mg/dL 142.1±86.6 74.6±37.9 <0.001
HDL-C, mg/dL 48.4±10.6 59.0±11.8 <0.001
Data are presented as means±standard deviation.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic 
blood pressure; HDL-C, high density lipoprotein cholesterol.
Table 2.  Menstrual history in women with type 2 diabetes 
and control subjects
Variable
Diabetics 
(n=118)
Control 
(n=258)
P value
Menstrual cycle, day
Current 32.2±8.4 30.2±6.4 0.02
Menarche to 19 yr old 32.9±12.9 31.9±12.8 0.5
20 to 29 yr old 32.8±10.0 31.4±10.4 0.2
Duration, day 5.2±1.7 4.9±1.4 0.01
Age at menarche, yr old 15±2 15±2 0.2
OM during 20s
a, % 16.1 8.5 0.03
Data are presented as means±standard deviation.
OM, oligomenorrhea. 
aOligomenorrhea was defined as a menstrual cycle length >40 days 
during participant’s 20s.
Fig. 2.  Frequency of oligomenorrhea from age 20 to 29 in 
obese and non-obese women with type 2 diabetes and controls.
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gomenorrhea and diabetes, the OR of obesity X oligomenor-
rhea was 2.27 (95% CI, 1.11 to 4.66; P value for Breslow-Day 
test for homogeneity=0.09; data not shown). In obese sub-
jects, diabetes was significantly associated with oligomenor-
rhea before and after adjusting for age and BMI, which was 
not replicated in the non-obese subjects (Table 4). 
DISCUSSION
In this study, we observed that the frequency of oligomenor-
rhea during women’s 20s was almost two-fold higher in wom-
en with type 2 diabetes than in the control subjects. The fre-
quency was 18.9% in obese women with type 2 diabetes, 13.9% 
in non-obese type 2 diabetes and 8.5% in the control group. 
  Type 2 diabetes is a common endocrine disorder with high 
prevalence in women of reproductive age. Several studies have 
reported an increased prevalence of amenorrhea and other 
menstrual irregularities in diabetic women. 
  Having a long interlude between menstrual cycles is a risk 
factor of type 2 diabetes. Solomon et al. [5] reported that wom-
en with long (40 or more days) or highly irregular menstrual 
cycles had a significantly increased risk of developing type 2 
diabetes in a 6-year follow-up study of the NHS II cohort. We 
observed that women with type 2 diabetes had significantly 
longer menstrual cycles than the control group (32.52±8.4 vs. 
30.2±6.4 days, P=0.02), and the frequency of oligomenorrhea 
in their 20s was almost two-fold higher in women with type 2 
diabetes than in the control subjects. This association was also 
seen in the multiple logistic regression analysis, after adjusting 
for age, obesity and various lifestyle habits, such as regular ex-
ercise, smoking, and alcohol consumption. 
  Irregular menstrual cycle and type 2 diabetes share common 
risk factors such as obesity, hyperinsulinemia and a more cen-
tral distribution of fat [10,11]. Obesity is related to the increased 
peripheral conversion of androgens to estrogens in the adipose 
tissue [12,13]. This becomes a major risk factor for type 2 dia-
betes, associated with infertility and menstrual abnormalities 
[7]. Higher estrogen concentrations result in menstrual ab-
normalities and anovulation by negative feedback at the hypo-
thalamo-pituitary level [14]. In our data, the association be-
tween menstrual irregularity and type 2 diabetes was strongest 
in women with a BMI greater than 25 kg/m
2, demonstrating 
that obesity increases the risk of type 2 diabetes and menstrual 
irregularity. 
  Insulin resistance and hyperinsulinemia are also associated 
with having an irregular menstrual cycle. The mechanism of 
insulin action on the ovaries leads to hyperinsulinemia result-
ing in excessive androgen production, leading to menstrual 
cycle disturbances and decreased fertility rates [14]. Insulin 
resistance and the associated beta cell dysfunction predispose 
a person to type 2 diabetes and high insulin levels often pre-
dict the progression to type 2 diabetes [15]. Hyperinsulinemia 
seems to synergize with pituitary gonadotropins to stimulate 
ovarian theca cell androgen production, exacerbating the in-
sulin resistance [16]. Elevated testosterone levels have also 
been reported as the cause for oligomenorrhea in women with-
out clinical hyperandrogenism [17].
  Hyperinsulinemia inhibits sex hormone-binding globulin 
Table 3.  Multiple logistic regression analysis for the risk of 
type 2 diabetes 
Variable OR 95% CI
Age 1.26 1.17–1.36
BMI 1.21 1.08–1.35
SBP 1.01 0.97–1.05
DBP 1.00 0.95–1.06
Triglycerides 3.65 1.85–7.19
HDL-C 0.96 0.93–0.99
OM
a 3.89 1.37–11.04
Triglycerides were analyzed after log transformation. Covariates were 
age, BMI, SBP, triglycerides, and HDL-C. 
OR, odds ratio; CI, confidence interval; BMI, body mass index; SBP, 
systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high 
density lipoprotein cholesterol; OM, oligomenorrhea.
aOM was defined as a menstrual cycle >40 days during the participant’s 
20s. 
Table 4.  Frequency and odds ratio of type 2 diabetes accord-
ing to obesity and oligomenorrhea during the participant’s 20s 
Total sub-
jects, no.
Subjects with 
diabetes, no. 
(%) 
Crude  
OR
Adjusted
a 
OR
Obese (BMI ≥25 kg/m
2, n=94)
OM (-) 83  43 (51.8)  1 1
OM (+) 11 10 (90.9)  9.0 (1.1-75.9) 9.7 (1.1-89.6)
Non-obese (BMI <25 kg/m
2, n=282)
OM (-) 252 56 (22.2) 1 1
OM (+) 30 9 (30.0) 1.5 (0.7-3.5) 1.8 (0.6-5.2)
OM was defined as a menstrual cycle >40 days during the partici-
pant’s 20s. 
OM, oligomenorrhea; OR, odds ratio; BMI, body mass index.
aAdjusted for age and BMI. 388
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(SHBG) production by the liver [18], and is associated with 
low SHBG concentrations, which leads to higher free testos-
terone concentrations [19]. Low SHBG concentration is also a 
risk factor for type 2 diabetes in women [20].
  PCOS is characterized by anovulation, androgen excess and 
insulin resistance [8]. Many women with PCOS are insulin re-
sistant and approximately 20% of obese women with PCOS 
have impaired glucose tolerance [21]. Studies of adolescent 
girls with PCOS show that insulin resistance is present early in 
the course of the syndrome [22-24]. The high prevalence of 
these risk factors among adolescent girls with PCOS puts them 
at an increased risk for developing type 2 diabetes [25]. In wom-
en with PCOS, hyperinsulinemia contributes to hyperan-
drogenism by increasing ovarian androgen production and 
decreasing SHBG [26]. A decrease in plasma insulin results in 
an increase in SHBG with a concurrent decrease in free testos-
terone, and these changes are consistent with the concept that 
insulin is a direct negative regulator of hepatic SHBG produc-
tion [27-29]. 
  There are some limitations to our study. One limitation is 
that the small sample size does not allow for the generalization 
of our results. Secondly, it is possible that while there may be 
an interaction between obesity, oligomenorrhea and diabetes, 
obesity could be a confounding factor. However, we adjusted 
for BMI in both the obese and non-obese groups and the OR 
remained markedly higher in obese subjects, as compared to 
the non-obese subjects. Thirdly, we did not measure testoster-
one levels and hirsutism scores in all of the participants. There-
fore, there may have been women with undiagnosed PCOS in 
the diabetic group, which could have affected the results. Obe-
sity could have also been a confounding factor in the diabetic 
group, however, we did not ask about any weight change from 
age 20 to current age. Finally, there could be a recall bias. Since 
women in our study self-reported any history of long or irreg-
ular menstrual cycles during their adolescence and from age 
20 to 29, recall bias could have interfered with the study results. 
Studies on validity and reliability of recall of early menstrual 
history have shown limitations in accuracy and precision [30-
33]. However, studies examining menstrual data as an expo-
sure measure continue to rely on retrospective data, given the 
expense and subject burden associated with gathering this data 
prospectively. In conclusion, we observed an association be-
tween women who currently have type 2 diabetes and having 
had a long menstrual cycle before being diagnosed as type 2 
diabetic. Long menstrual cycles may be an important risk fac-
tor for the development of type 2 diabetes in women. Howev-
er, prospective studies will be required to assess the causality. 
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